Literature DB >> 24501246

Bone erosions in rheumatoid arthritis: ultrasound findings in the early stage of the disease.

Maria-Magdalena Tămaş, Emilio Filippucci, Andrea Becciolini, Marwin Gutierrez, Luca Di Geso, Karina Bonfiglioli, Paraskevi V Voulgari, Fausto Salaffi, Walter Grassi.   

Abstract

OBJECTIVE: The objective of this study was to determine the prevalence and distribution of bone erosions detectable by US in patients with early RA (ERA) in comparison with long-standing RA (LSRA), other erosive diseases and healthy controls.
METHODS: Thirty patients with ERA and 80 patients with LSRA were consecutively recruited. Thirty patients with PsA, 15 with primary OA, 10 with gout and 20 healthy subjects were included as controls. Bone erosions were investigated at the following anatomical sites: the second and fifth metacarpal heads, the ulnar head and the first and fifth metatarsal heads, bilaterally. Dorsal, volar and lateral aspects were explored on longitudinal and transverse views.
RESULTS: At least one US bone erosion was found in 20 (66.7%) of 30 patients with ERA and in 10 (33%) of them it was found on the fifth metatarsal head. Bone erosions were most frequently found on the lateral quadrants of all scanned anatomical sites. If the second and fifth metacarpal heads and the fifth metatarsal head were scanned, an erosive disease could be found in 60% of ERA patients. The first metatarsal head was most frequently involved in the disease control group.
CONCLUSION: This study found a high percentage of ERA patients with US bone erosions, with the fifth metatarsal head and the lateral aspects the most frequently involved site and quadrants. US scanning for bone erosions on a few target joints was found feasible and provided information not obtainable with clinical examination.

Entities:  

Mesh:

Year:  2014        PMID: 24501246     DOI: 10.1093/rheumatology/ket484

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  15 in total

1.  A descriptive, cross-sectional study characterizing bone erosions in rheumatoid arthritis and gout by ultrasound.

Authors:  Lucio Ventura-Ríos; Cristina Hernández-Díaz; Guadalupe Sanchez-Bringas; Eduardo Madrigal-Santillán; José Antonio Morales-González; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2016-07-09       Impact factor: 2.980

2.  Musculoskeletal imaging of the inflammatory and degenerative joints: current status and perspectives.

Authors:  Fausto Salaffi; Marina Carotti; Antonio Barile
Journal:  Radiol Med       Date:  2019-02-27       Impact factor: 3.469

3.  How is the ultrasound in rheumatology used, implemented, and applied in Latin American centers? Results from a multicenter study.

Authors:  Marwin Gutierrez; Cristina Hernandez-Diaz; Lucio Ventura-Rios; Lina María Saldarriaga-Rivera; Santiago Ruta; Magaly Alva; Claudia Mora -Trujillo; Wilkerson Pérez; Henry Terrazas; Rodolfo Del Carmen Arape Toyo; Maritza Quintero; Carla Solano; Oscar Sedano Santiago; Janet Grisel Huamán Sotomayor; Cesar Cefferino; Guillermo E Py; Marcelo J Audisio; Walter Javier Spindler; Horacio Berman; Carla Airoldi; Rómulo Wong; Ana Laura Álvarez Del Castillo Araujo; Mario E Díaz; Carmen Cerón Villaquiran; Rubén Darío Mantilla; José Alexandre Mendonça; Inês Guimarães da Silveira; Aline Defaveri do Prado; Melissa Cláudia Bisi; Violeta Rosario; Jeannette Medrano-Sánchez; Roberto Muñoz-Louis; Ana Cecilia Lozada-Navarro; Araceli Bernal; Maribel Lozano; Carlos Pineda
Journal:  Clin Rheumatol       Date:  2016-08-30       Impact factor: 2.980

4.  Level of agreement between three-dimensional volumetric ultrasound and real-time conventional ultrasound in the assessment of synovitis, tenosynovitis and erosions in rheumatoid arthritis patients.

Authors:  Carlos Acebes; Neil McKay; Anna Ciechomska; Nicola Alcorn; John P Harvie; Barbara Robson; Nico Groenendijk; Moira McDonald; Alison Wilson; Jesus Garrido
Journal:  Rheumatol Int       Date:  2016-11-28       Impact factor: 2.631

Review 5.  Ultrasound imaging in rheumatoid arthritis.

Authors:  Emilio Filippucci; Edoardo Cipolletta; Riccardo Mashadi Mirza; Marina Carotti; Andrea Giovagnoni; Fausto Salaffi; Marika Tardella; Andrea Di Matteo; Marco Di Carlo
Journal:  Radiol Med       Date:  2019-03-09       Impact factor: 3.469

Review 6.  Should ultrasound be used routinely in the diagnosis of rheumatoid arthritis?

Authors:  Maria Boylan
Journal:  Ir J Med Sci       Date:  2019-10-23       Impact factor: 1.568

7.  VEGF Profile in Early Undifferentiated Arthritis Cohort.

Authors:  Regina Sakalyte; Loreta Bagdonaite; Sigita Stropuviene; Sarune Naktinyte; Algirdas Venalis
Journal:  Medicina (Kaunas)       Date:  2022-06-20       Impact factor: 2.948

8.  ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography.

Authors:  Julien Grosse; Edem Allado; Camille Roux; Audrey Pierreisnard; Marion Couderc; Isabelle Clerc-Urmes; Thomas Remen; Éliane Albuisson; Marcelo De Carvalho-Bittencourt; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  Rheumatol Int       Date:  2019-12-13       Impact factor: 2.631

Review 9.  Osteoimmunology: Major and Costimulatory Pathway Expression Associated with Chronic Inflammatory Induced Bone Loss.

Authors:  Tania N Crotti; Anak A S S K Dharmapatni; Ekram Alias; David R Haynes
Journal:  J Immunol Res       Date:  2015-05-03       Impact factor: 4.818

10.  Ultrasound-detected bone erosion is a relapse risk factor after discontinuation of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis whose ultrasound power Doppler synovitis activity and clinical disease activity are well controlled.

Authors:  Shin-Ya Kawashiri; Keita Fujikawa; Ayako Nishino; Akitomo Okada; Toshiyuki Aramaki; Toshimasa Shimizu; Masataka Umeda; Shoichi Fukui; Takahisa Suzuki; Tomohiro Koga; Naoki Iwamoto; Kunihiro Ichinose; Mami Tamai; Akinari Mizokami; Hideki Nakamura; Tomoki Origuchi; Yukitaka Ueki; Kiyoshi Aoyagi; Takahiro Maeda; Atsushi Kawakami
Journal:  Arthritis Res Ther       Date:  2017-05-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.